This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Carla Odio, MD; Edgar Mohs, MD; Fred H. Sklar, MD; John D. Nelson, MD; George H. McCracken, Jr, MD

Am J Dis Child. 1984;138(1):17-19.

Abstract
• From January to May 1982, 37 children undergoing CSF shunt procedures in two different countries were enrolled in a randomized, double-blind, controlled study to receive vancomycin hydrochloride (15 mg/kg/dose) or placebo (saline) one hour before surgery and again six hours later. Twenty patients received vancomycin, and 17 received placebo. In the 35 cases that could be evaluated, shunt-associated infections developed in three (17%) of 18 patients who received vancomycin and in four (23%) of the 17 placebo recipients. All infections were caused by Staphylococcus species susceptible to vancomycin. A histaminelike rash developed in seven (35%) of 20 patients during vancomycin infusion. It recurred with readministration in one patient and was accompanied by hypotension in another patient. The reactions were not related to too rapid infusion of vancomycin. Because of the adverse reactions to vancomycin, the study was discontinued.

(AJDC 1984;138:17-19)

Author Affiliations
From the Departments of Pediatrics (Drs Odio, Nelson, and McCracken) and Neurosurgery (Dr Sklar), University of Texas Health Science Center, Dallas, and the Children's National Hospital, San Jose, Costa Rica (Dr Mohs).

Footnotes
Reprint requests to University of Texas Health Science Center, 5323 Harry Hines Blvd, Dallas, TX 75238 (Dr Odio).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The ethics of prophylactic antibiotics for neurosurgical procedures
Savitz et al.
J. Med. Ethics 2002;28:358-363.
ABSTRACT | FULL TEXT  

Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections
Finkelstein et al.
J. Thorac. Cardiovasc. Surg. 2002;123:326-332.
ABSTRACT | FULL TEXT  

Ability of teicoplanin and vancomycin to induce contraction of, and histamine release from, pulmonary tissue of humans, monkeys and guinea pigs
Nabe et al.
J Antimicrob Chemother 1999;43:233-242.
ABSTRACT | FULL TEXT  

The "Red Man's Syndrome" and Slow Infusion of Vancomycin
DAVIS et al.
ANN INTERN MED 1986;104:285-286.
ABSTRACT